Seroepidemiology of HTLV-I/II in Argentina: An Overview

Journal of Acquired Immune Deficiency Syndromes

Volumn 35, Issue 3, 2004, Pages 301-308

  Gastaldello, Rene ^a   Hall, William W ^b   Gallego, Sandra ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Argentina; Human T lymphotropic virus type I (HTLV I); Human T lymphotropic virus type II (HTLV II)

Indexed keywords

ARGENTINA; BLOOD DONOR; FEMALE; HEMOPHILIA; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; REVIEW; SCREENING; SEROEPIDEMIOLOGY; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION;

ARGENTINA; BLOOD DONORS; GEOGRAPHY; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 1442348439     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200403010-00012     Document Type: Review

References (75)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77: 7415-7419.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218:571-573.
3. Shimotohno K, Takahashi Y, Shimizu N, et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci USA. 1985; 82:3101-3105.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79:2031-2035.
5. Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1992;117:933-946.
6. Jacobson S. Cellular immune responses to HTLV-1: immunopathogenic role in HTLV-I associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl):S100-S106.
7. Murphy E. The clinical epidemiology of human T-lymphotropic virus type II (HTLV-II). J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 13(Suppl):S215-S219.
8. Okochi K, Sato H, Himuna Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1994;46:245-253.
9. Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, -II and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133-3137.
10. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992;326:375-380.
11. Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989;111:555-560.
12. Kajiyama W, Kashiwagi S, Ikernatsu H, et al. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis. 1986;154:851-857.
13. Hino S, Katamine S, Miyamoto T, et al. Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal ami-env antibodies correlate with protection in non-breast-fed children. J Clin Invest. 1995;95: 2920-2925.
14. Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science. 1989;244:471-475.
15. Ehrlich GD, Glaser JB, La Vigne K, et al. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type specific identification of HTLVs by polymerase chain reaction. Blood. 1989;74:1658-1664.
16. Van Dyke RB, Heneine W, Perrin ME, et al. Mother-to-child transmission of human lymphotropic virus type II. J Pediatr. 1998;127:924-928.
17. Meytes D, Schochat B, Lee H, et al. Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet. 1990;336: 1533-1535.
18. Hjelle B. Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis. Arch Pathol Lab Med. 1991;115: 440-450.
19. Kazura JW, Saxinger WC, Wenger J, et al. Epidemiology of human T cell leukemia virus type I infection in East Sefek province, Papua New Guinea. J Infect Dis. 1987;155:1100-1107.
20. Yanagihara R, Ajdukiewicz AB, Garruto RM, et al. Human T-lymphotropic virus type I infection in the Salomon Islands. Am J Trop Med Hyg. 1991;44:122-130.
21. Tajima K, Hinuma Y. Epidemiology of HTLV-I/II in Japan and the world. Gann Monogr Cancer Res. 1992;39:129-149.
22. Galvao Castro B, Lourdes L, Ferreira OC, et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion. 1997;37:242-243.
23. Gabbai AA, Bordin JO, Vieira-Filho JP, et al. Selectivity of T human lymphotropic virus type I (HTLV-I) and HTLV-II infection among different populations in Brazil. Am J Trop Med Hyg. 1993;49:664-671.
24. Muchinick G, Bouzas MB, Zapiola I, et al. HTLV-I and HTLV-II infection in Uruguay. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5: 743-744.
25. Vasquez P, Sanchez G, Volante C, et al. Human T-lymphotropic virus type I: new risk for Chilean population. Blood. 1991;78:850-851.
26. Hurtado L, Gomez L, Andrada R, et al. HTLV-I infection and diseases in Bolivian population [ED 13]. Presented at the Eighth International Conference on Human Retrovirology: HTLV, Rio de Janiero, Brazil; June 9-13, 1997.
27. Hall WW, Ishak R, Zhu SW. Human T-lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl): S204-S214.
28. Fukushima Y, Takahashi H, Hall WW, et al. Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res Hum Retroviruses. 1995;11:637-645.
29. Hall WW, Kubo T, Ijichi S, et al. Human T cell leukemia/lymphoma virus type II (HTLV-II): emergence of an important newly recognized pathogen. Semin Virol. 1994;5:165-178.
30. Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet. 1990;336:575-576.
31. Zella D, Cavicchini A, Salemi M, et al. Molecular characterization of two isolates of human T cell leukemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol. 1993;74:437-444.
32. Fujiyoshi T, Li H, Lou HC, et al. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses. 1999;15:1235-1239.
33. Bouzas MB, Muchinik G, Zapiola I, et al. Prevalence of HTLV-I/II among blood bank donors in Argentina. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:1275-1276.
34. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in US blood donors. Science. 1988; 240:643-646.
35. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med. 1990;322:383-388.
36. Blejer JL, Saguier MC, Salomone HJ, et al. Determination of anti-HTLV-I/II antibodies: experience in 28,897 blood donations in Buenos Aires. Sangre (Barc). 1995;40:447-451.
37. Pintado A, Gastaldo S, Mursi S, et al. HTLV-I prevalence in blood banks of Jujuy, North Western Argentina [ED 12]. Presented at the Eight International Conference on Human Retrovirology: HTLV, Rio de Janeiro, Brazil, June 9-13, 1997.
38. Biglione M, Pizarro M, Crespo O, et al. High prevalence of HTLV-I infection in Argentinean blood donors: a new HTLV-I endemic area? J Acquir Immune Defic Syndr. 1999;20:101-102.
39. Remondegui C. Paraparesia espȧstica tropical por HTLV-I en la provincia de Jujuy. Boletín sobre el SIDA en la Argentina. 1998;14:20-28.
40. Garay M, Ortega M, Guanca P, et al. HTLV-I/II among blood donors and HIV positive patients from Salta, Argentina [P101:A55]. Presented at the Ninth International Conference on Human Retrovirology: HTLV, Kagoshima, Japan, April 5-9, 1999.
41. Rodríguez C, Biglione M, Muracciole D, et al. Seroprevalencia de HTLV-I/II en la ciudad de Formosa [P010]. Presented at the VI Congreso Argentino de Virología, Buenos Aires, August 29-31, 1999.
42. Ferrer JF, Del Pino N, Esteban E, et al. High rate of infection with the human T-cell leukemia retrovirus type II in four Indians populations of Argentina. Virology. 1993;197:576-584.
43. Rodríguez C, Ayala C, Muracciole D, et al. Seroprevalencia de HTLV-I/II en la provincia de Formosa. Año 2001 [P251]. Presented at the IX Congreso Argentino de Microbiología, Buenos Aires, October 7-11, 2001.
44. Gallego S, Maturano E, Recalde A, et al. Seroprevalencia de HTLV-I/II y factores de riesgo asociados a la infección en la población de donantes de sangre de Córdoba, Argentina. Rev Arg Microbiol. 2001;33:182-186.
45. Gallego S, Gastaldello R, Maturano E, et al. Detección de marcadores de infección por HTLV-I/II en la población de bajo riesgo de la provincia de Córdoba, año 2000 [P238]. Presented at the IX Congreso Argentino de Microbiología, Buenos Aires, October 7-11, 2001.
46. Gastaldello R, Fazzola P, Caeiro L, et al. Ausencia de circulación de los virus HTLV-I/II en donantes de sangre de las provincias de Santa Fé y Santiago del Estero. Rev Arg Microbiol. 2002;34:107-109.
47. Blejer JL, Natalutti GR, Garcia MM, et al. Infecciones por Retrovirus en donantes de sangre. Rev Arg Transf. 2001;27(Set):25-26.
48. Iriarte E, Jones M, Cabrini S, et al. Prevalencia de HTLV-I/II en un banco de sangre de Entre Ríos. Rev Arg Transf. 2001;27(Set):29-30.
49. Manns A, Blattner WA. The epidemiology of the human T-cell lymphotropic virus type I and type II: etiologic role in human disease. Transfusion. 1991;31:67-75.
50. Sherman MP, Saksena NK, Dube DK, et al. Evolutionary insights on the origin of human T-cell lymphoma-leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol. 1992;66:2556-2563.
51. Heneine W, Kaplan JE, Gracia F, et al. HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med. 1991;324:565.
52. Hjelle B, Mills R, Swenson S, et al. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II endemic population. J Infect Dis. 1991;163:435-440.
53. Maloney EM, Biggar RJ, Neel JV, et al. Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis. 1992;166:100-107.
54. Levine PH, Jacobson S, Elliott R, et al. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses. 1993;9:123-127.
55. Duenas-Barajas E, Bernal JE, Vaught DR, et al. Coexistence of human T-lymphotropic virus type I and II among Wayuu Indians from the Guajua region of Colombia. AIDS Res Hum Retroviruses. 1992;8:1851-1855.
56. Duenas-Barajas E, Bernal JE, Vaught DR, et al. Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians. Am J Trop Med Hyg. 1993;49:657-663.
57. Dube DK, Sherman MP, Saksena NK, et al. Genetic heterogenicity in human T-cell leukemia/lymphoma virus type II. J Virol. 1993;67:1175-1184.
58. Bouzas MB, Zapiola I, Quiruelas S, et al. HTLV type I and HTLV type II infection among Indians and natives from Argentina. AIDS Res Hum Retroviruses. 1994;10:1567-1571.
59. Biglione M, Vidan O, Mahieux R, et al. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Matacos and Tobas Indians of northern Argentina. AIDS Res Hum Retroviruses. 1999;15:407-417.
60. Ferrer JF, Esteban E, Dube S, et al. Endemic infection with human T-cell leukemia/lymphoma virus type IIB in Argentinean and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis. 1996;174: 944-953.
61. Medeot S, Nates S, Recalde A, et al. Prevalence of antibody to human T-cell lymphotropic virus type 1/2 among aboriginal groups inhabiting Northern Argentina and the Amazon region of Peru. Am J Trop Med Hyg. 1999;60:623-629.
62. Lombardi V, Carrillo MG, Alimandi M, et al. Overt and latent HIV-I and HTLV-I infection in cohorts of a high risk individuals in Argentina. Mol Cell Probes. 1991;5:409-417.
63. Pampuro S, Rabinovich R, Martinez Peralta L, et al. Presence of human T-cell lymphotropic virus type I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina. J Acquir Immune Defic Syndr Hum Retrovirol. 1993;6:851-852.
64. Zapiola I, Salomone S, Alvarez A, et al. HIV-1, HIV-2, HTLV-I/II and STD among female prostitutes from Buenos Aires, Argentina. Eur J Epidemiol. 1996;12:27-31.
65. Medeot S, Nates S, Gallego S, et al. HTLV-I/II seropositivity in populations at high risk for HIV-I infection in Córdoba City, Argentina. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:187-188.
66. Brennan M, Runganga J, Barbara JA, et al. Prevalence of antibodies to human T-cell leukemia lymphoma in blood donors in North London. BMJ. 1993;307:1235-1239.
67. Coste J, Lemaire JM, Barin F, et al. HTLV-I/II antibodies in French blood donors. Lancet. 1990;335:1167-1168.
68. Lee HH, Swanson P, Rosenblatt JD, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in U.S. blood donors. Lancet. 1991;337:1435-1439.
69. Tajima K, Tominaga S, Suchi T, et al. Epidemiological analysis of distribution of antibody to adult T-cell leukemia virus associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gann. 1982; 73:893-901.
70. Kusuhara K, Sonoda S, Takahashi K, et al. Mother-to-child transmission of human T cell leukemia virus type I (HTLV-I): a fifteen-year follow up study in Okinawa, Japan. Int J Cancer. 1987;40:755-757.
71. Constantine NT, Bonsal J, Marsiglia VC. HIV-I and HTLV-I/II coinfection in Baltimore. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5: 535-536.
72. Williams AW, Fang CT, Sandler G. HTLV-I/II and blood transfusion in the United States. In: Blattner WA, ed. Human Retrovirology HTLV. New York: Raven Press; 1990:349-362.
73. Ferreira Junior OC, Vaz RS, Carvalho MB, et al. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from Sao Paulo, Brazil. Transfusion. 1995;35:258-263.
74. Zaaijer H, Cuypers H, Dudok de Wit C, et al. Results of 1-year screening of donors in the Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion. 1994;10:877-880.
75. Gastaldello R, Gallego S, Isa MB, et al. Immunofluorescence assay reactivity patterns of serum samples presenting indeterminate Western blot results for antibodies to HIV-I and HTLV-I/II in Córdoba, Argentina. Rev Inst Med Trop S Paulo. 2002;43:277-282.